Short interest for Fulgent Genetics gives investors a sense of the degree to which investors are betting on the decline of Fulgent Genetics's stock. Short interest data is updated every two weeks.

Fulgent Genetics Stock (NASDAQ:FLGT), Short Interest Report

Fulgent Genetics

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Earnings

News

Guidance

Health Care

Small Cap

Movers

Trading Ideas

General

FLGT

Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.&lt;

Why Is Fulgent Genetics Stock Moving Higher Today?

Penny Stocks

HOTH

Why Fulgent Genetics Shares Are Trading Higher Today

Biotech

ABCL

ADGI

AGIO

ARYD

AXNX

BMRN

CDNA

CDXS

CLNN

COLL

EDIT

FOLD

GTHX

ICUI

IOVA

LMAT

LUNG

MGNX

MMSI

MRNA

NTRA

NVTA

ORPH

OTIC

PCRX

SAGE

SGMO

SILK

TMDX

TVTX

VCEL

VNDA

YMAB

Here&#39;s a roundup of top developments in the biotech space over the last 24 hours:

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

Fulgent Genetics Inc

Stephens &amp; Co. analyst Sudan Loganathan initiates coverage on Delcath Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCTH#NASDAQ">DCTH</a>) with a Overweight rating and announces Price Target of $25.

Price Target

Initiation

Analyst Ratings

DCTH

Stephens & Co. Initiates Coverage On Delcath Systems with Overweight Rating, Announces Price Target of $25

Needham analyst Serge Belanger maintains Verrica Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRCA#NASDAQ">VRCA</a>) with a Buy and raises the price target from $8 to $16.

VRCA

Needham Maintains Buy on Verrica Pharmaceuticals, Raises Price Target to $16

Macro Economic Events

Econ #s

Economics

Eurozone ZEW Economic Sentiment For May 47 Vs. 46.1 Est.; 43.9 Prior

Needham analyst Quinn Bolton reiterates D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) with a Buy and maintains $2.5 price target.

Reiteration

QBTS

Needham Reiterates Buy on D-Wave Quantum, Maintains $2.5 Price Target

Germany ZEW Economic Sentiment For May 47.1 Vs. 44.9 Est.; 42.9 Prior

Germany ZEW Current Conditions For May -72.3 Vs. -75.0 Est.; -79.2 Prior

In a move signaling increased military cooperation, the U.S. and Taiwan navies reportedly conducted undisclosed joint exercises in the Pacific last month. This development comes in response to escalating threats from Xi Jinping&#8217;s Chinese military.
What Happened: These unconfirmed drills took place in the Western Pacific, Reuters reported on Tuesday. The sources, who requested anonymity, indicated that the exercises incorporated &#8220;multiple military assets.&#8221;
Termed unofficially as &#8220;unplanned sea encounters,&#8221; the drills suggest a tacit understanding between both nations to portray the exercises as coincidental encounters. 
&#8220;It&#8217;s like I am dining in this restaurant and you also happen to be here,&#8221; one source said.
Around half a dozen navy ships from both sides, including frigates and supply and support vessels, were involved in the days-long exercises. The drills were centered on &#8220;basic&#8221; operations such as communications, refueling, and resupply.
See Also: <a href="https://www.benzinga.com/news/24/05/38668133/xi-jinping-says-he-would-never-forget-natos-bombing-of-chinese-embassy-25-years-ago-will-never-allow?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Xi Jinping Says He Would &#8216;Never Forget&#8217; NATO&#8217;s Bombing Of Chinese Embassy 25 Years Ago: &#8216;Will Never Allow</a>
The Pentagon and Chinese Defense Ministry have not responded on the matter.
Why It Matters: Amid almost daily Chinese incursions into Taiwan&#8217;s air defense identification zone and drills by Chinese forces near the island, the U.S. and Taiwan have been bolstering their military cooperation in recent years. However, due to China&#8217;s opposition to any military contacts between Washington and Taipei, such engagements are often kept under wraps and not officially confirmed.
These exercises are vital to ensure that the two militaries can operate together during emergencies, as per another source. The source further stated that the two navies also practiced various tactical maneuvers, including searching for underwater targets.
Despite <a href="https://www.benzinga.com/news/24/05/38574814/us-backs-taiwans-who-assembly-participation-amid-chinas-objections">U.S. backing for Taiwan&#8217;s participation in global organizations</a> and continued security assistance, Taiwan&#8217;s leadership has emphasized the <a href="https://www.benzinga.com/news/24/05/38638573/taiwans-vice-president-elect-calls-for-building-our-own-strengths-first-despite-us-support-amid-cris">importance of self-strengthening.</a> This comes amid concerns over <a href="https://www.benzinga.com/news/24/04/38177328/chinas-tricks-with-fake-ai-videos-in-taiwan-stir-worries-for-us-2024-elections">China&#8217;s disinformation campaigns</a> during Taiwan's national elections.
Read Next: <a href="https://www.benzinga.com/markets/asia/24/05/38782261/china-greenlights-another-big-tesla-factory-this-time-for-megapack-project?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">China Greenlights Another Big Tesla Factory, This Time For Megapack Project</a>
Photo by Andy.LIU Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Politics

Global

US And Taiwan Engage In Covert Joint Naval Exercises Amid Rising Threats From Xi Jinping's Army: Report

Roth MKM analyst Eric Handler downgrades Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) from Buy to Neutral and lowers the price target from $55 to $35.

Downgrades

RBLX

Roth MKM Downgrades Roblox to Neutral, Lowers Price Target to $35

Needham analyst Serge Belanger reiterates Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) with a Buy and maintains $108 price target.

CYTK

Needham Reiterates Buy on Cytokinetics, Maintains $108 Price Target

China has reportedly instructed its tech giants to reduce their reliance on foreign-made chips, particularly those from NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and increase their purchase of domestic AI chips.
What Happened: The Chinese government has advised major tech companies such as Alibaba Group Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), Baidu Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), ByteDance, and Tencent Holdings Ltd (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCEHY#OTC">TCEHY</a>) to decrease their spending on foreign-made-chips, including those from Nvidia, The Information <a href="https://www.theinformation.com/articles/chinese-regulators-tell-local-tech-firms-to-buy-fewer-nvidia-chips">reported</a> on Monday, citing people familiar with the matter.
These companies are now expected to purchase an equal number of locally and foreign-made AI chips for their new data centers.
The directive, as per The Information, has not been strictly enforced, and it is unclear if any penalties will be imposed for non-compliant companies.
China&#8217;s new directive poses a significant challenge for Nvidia, which has been striving to provide specialized offerings for the Chinese market. The company is developing three new GPUs for China, designed to meet the restrictions under prevailing U.S. sanction rules.
China is a critical market for Nvidia, accounting for 19% of its data center chip revenue in fiscal year 2023. However, U.S. export restrictions have caused a significant drop in China&#8217;s revenue share, a matter of concern for Nvidia.
Representatives for China&#8217;s Ministry of Industry and Information Technology, Alibaba, Baidu, ByteDance, and Tencent did not immediately respond to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga</a>'s request for comment.
See Also: <a href="https://www.benzinga.com/markets/asia/24/05/38760872/us-ready-to-impose-new-tariffs-on-chinas-ev-solar-sectors-could-cause-more-severe-damage-than-last-t?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">US Ready To Impose New Tariffs On China&#8217;s EV, Solar Sectors: &#8216;Could Cause More Severe Damage&#8217; Than Last T</a>
Why It Matters: This move by China comes at a time when the global supply of high-performance memory chips is expected to remain constrained throughout 2024, driven by the <a href="https://www.benzinga.com/news/24/05/38807448/high-performance-memory-chip-supply-to-stay-tight-in-2024-amid-surging-ai-demand-major-manufacturers">soaring demand for artificial intelligence</a> technology. This is likely to affect the supply of these chips for the rest of 2024 and well into 2025.
Gaining control over the global supply of chips is becoming a central priority for Western governments trying to compete with China in the race to dominate the industry. This is part of the reasoning behind a long list of sizable investments that governments are pouring on their <a href="https://www.benzinga.com/markets/asia/24/05/38800273/chinas-semiconductor-spending-tops-us-with-142b-commitment-global-chip-race-heats-up">domestic building capabilities</a>. Subsidies are expected to reach hundreds of billions of dollars in the coming decade.
HSBC Global Research maintained Nvidia with a Buy rating Monday and lifted its 12-month price target as the firm believes the chipmaker's strong pricing power will allow the company to continue to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38798378/hsbc-analyst-sees-nvidia-stock-climbing-another-50-on-strong-pricing-power-ai-roadm">deliver upside surprises</a> through fiscal year 2026.
With the U.S. and China set to discuss the potential risks of advanced artificial intelligence, the talks will explore ways to mitigate the potential dangers of this emerging technology. The Biden administration has been actively seeking to engage China on various issues to minimize <a href="https://www.benzinga.com/news/24/05/38783544/us-china-to-discuss-ai-risks-in-geneva-will-washingtons-policies-be-up-for-negotiation">misunderstandings between the two countries</a>. The talks on AI were initiated following a discussion between U.S. Secretary of State Antony Blinken and China's Foreign Minister Wang Yi in April.
Read Next: <a href="https://www.benzinga.com/news/24/05/38788479/china-refutes-philippines-claims-of-creating-artificial-island-in-south-china-sea-groundless-and-pur?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">China Refutes Philippines Claims Of Creating Artificial Island In South China Sea: &#8216;Groundless And Pure Fabrication&#8217;</a>
Image Via Shutterstock 
<hr class="wp-block-separator has-alpha-channel-opacity" />
Engineered by Benzinga Neuro, Edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Learn more.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />

Equities

Markets

Tech

ASML

BABA

BIDU

INTC

NVDA

TCEHY

China Urges Tech Giants To Shift Away From Nvidia And Other Foreign Chip Makers, Boost Domestic AI Chip Purchases: Report

A financial expert has issued a warning to investors about the potential risks associated with meme stocks, particularly GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>).
What Happened: Douglas Boneparth, a certified financial planner and the president of Bone Fide Wealth, advised investors to be cautious when considering meme stocks like GameStop, CNBC <a href="https://www.cnbc.com/2024/05/13/gamestop-stock-surge-why-investors-should-be-wary-of-meme-stocks.html">reported</a> on Monday. He emphasized the importance of understanding the motivations behind such investments.
&#8220;Retail investors need to be wary,&#8221; Boneparth said. 
&#8220;Is [fear of missing out] leading the way or is this legitimately a great opportunity to jump in?&#8221;
He suggested that investors should thoroughly research a company&#8217;s core business model and its long-term revenue plans before investing in any stock, meme stock or not.
See Also: <a href="https://www.benzinga.com/insights/options/24/05/38791263/check-out-what-whales-are-doing-with-pltr?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Check Out What Whales Are Doing With PLTR</a>
While acknowledging GameStop&#8217;s recent turnaround, Boneparth recommended a more hands-off approach for most investors, suggesting that exchange-traded funds and mutual funds provide automatic diversity by spreading investments across top-performing U.S. companies.
He also advised investors to think long-term and avoid using a company&#8217;s short-term performance to predict its future behavior.
Why It Matters: The warning from Boneparth comes at a time when <a href="https://www.benzinga.com/general/gaming/24/05/38798005/roaring-kitty-doubles-down-posts-new-videos-on-x-sending-gamestops-stock-higher">GameStop&#8217;s stock has been experiencing</a> significant volatility. The surge in GameStop&#8217;s stock was attributed to a series of posts by Keith Gill, also known as Roaring Kitty, on the social media platform X. This led to a frenzy in the meme stock community and a substantial increase in GameStop&#8217;s valuation.
Moreover, the Roaring Kitty mania also had a <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38807059/roaring-kitty-comeback-makes-cat-themed-coins-explode-roar-shoots-up-over-500">ripple effect on the meme coin market</a>, causing coins themed on kitty avatars to soar to unprecedented heights. This further highlights the influence of social media on the financial markets and the potential risks associated with meme stocks and cryptocurrencies.
Price Action: On Monday, GameStop closed 74.4% higher at $30.45 while it was trading 38.8% higher in the Tuesday pre-market at $42.25 at the time of writing, according to <a href="https://pro.benzinga.com">Benzinga Pro</a>.
Read Next: <a href="https://www.benzinga.com/news/24/05/38776732/biden-chief-economic-advisor-promises-relief-for-middle-class-sets-sights-on-overturning-corporate-t?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Biden Chief Economic Advisor Promises Relief For Middle Class, Sets Sights On Overturning Corporate Tax Cuts: Report</a>
Image via Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Analyst Color

Is GameStop Surge After 'Roaring Kitty' A 'FOMO'? Expert Warns 'Retail Investors Need To Be Wary'

Needham analyst Mike Cikos reiterates Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Buy and maintains $62 price target.

TENB

Needham Reiterates Buy on Tenable Holdings, Maintains $62 Price Target

Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has begun offering a <a href="https://www.benzinga.com/news/24/05/38798863/tesla-defies-auto-industry-trends-with-0-99-apr-model-y-financing-offer">heavily discounted 0.99% financing option for the purchase of its Model Y electric vehicles </a>in North America, and venture capitalist and Deepwater Management Partner Gene Munster offered his take on the development in a post on Monday.
Material Development: Tesla is the &#8220;master&#8221; at tweaking prices to optimize demand,&#8221; said Munster. The fund manager noted that demand has been soft over the past five months. He noted that Tesla buyers can save $8,000 over an average six-year loan with a 1% interest rate relative to a 7% rate.
While noting that a majority of cars are now purchased with some sort of financing, Munster said, &#8220;This is material and gives me confidence that June quarter deliveries will improve from March.&#8221;
The tech analyst said he expects a 1%-4% year-over-year decline in June quarter deliveries versus the 1% drop forecast by Street and the 9% drop seen in the March quarter. 
See Also:<a href="https://www.benzinga.com/money/best-electric-vehicle-stocks"> Best Electric Vehicle Stocks</a>
Not all share the same enthusiasm. Prominent short seller Jim Chanos sees this move as a camouflaged price cut. Replying to a Tesla fan&#8217;s comments that the reduced financing offer is an &#8220;absolute game changer,&#8221; the short seller said, &#8220;Who wants to tell him this is just another price cut…?&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Who wants to tell him this is just another price cut…? <a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> <a href="https://t.co/Cs5gZR7Rpa">https://t.co/Cs5gZR7Rpa</a>
&mdash; Diogenes (@WallStCynic) <a href="https://twitter.com/WallStCynic/status/1789396681051582499?ref_src=twsrc%5Etfw">May 11, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<figcaption class="wp-element-caption">Why It&#8217;s Important: After emerging out of the COVID-19 pandemic unscathed, Tesla&#8217;s fundamentals began to falter amid deteriorating economic conditions. Rising inflation ate away at consumers&#8217; disposable income and kept them from spending on discretionary items such as cars.</figcaption></figure>
Tesla went all out with the strategy of under-cutting competition to preserve its market share but it backfired as rivals followed suit. The price cuts have steeply eroded margins and profitability. 
The Elon Musk-led company has opted to go with the &#8220;razor-razorblade&#8221; strategy, by sacrificing the margins of the auto business to make up for the shortfall with a high-margin, recurring revenue stream by selling its full self-driving software.
In premarket trading, Tesla shares rose 0.29% to $172.38, according to<a href="https://benzinga.grsm.io/lxquj26b2sag"> Benzinga Pro data.</a>
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="http://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next: <a href="https://www.benzinga.com/news/24/05/38776258/tesla-ceo-elon-musk-draws-parallel-between-netflixs-decision-to-focus-on-streaming-over-renting-dvds">Tesla CEO Elon Musk Draws Parallel Between Netflix&#8217;s Decision To Focus On Streaming Over Renting DVDs To EV Maker Doubling Down On Vehicle Autonomy</a>
Photo courtesy: Shutterstock

Short Sellers

TSLA

Tesla's Genius Move Or Price Cut In Disguise? Analysts Dissect EV Giant's 0.99% Model Y Financing Scheme

<a href="https://www.reuters.com/business/autos-transportation/stellantis-leapmotor-start-sales-budget-evs-nine-european-countries-september-2024-05-14/" title="https://www.reuters.com/business/autos-transportation/stellantis-leapmotor-start-sales-budget-evs-nine-european-countries-september-2024-05-14/">https://www.reuters.com/business/autos-transportation/stellantis-leapmotor-start-sales-budget-evs-nine-european-countries-september-2024-05-14/</a>

STLA

Reuters Reported Stellantis, Leapmotor To Start Sales Of Budget EVs In Nine European Countries In September

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 20 points on Tuesday.
Shares of TeraWulf Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) fell sharply in today's pre-market trading after the company reported downbeat results for its <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38802344/bitcoin-miner-terawulf-reports-worse-than-expected-q1-results">first quarter on Monday</a>.
The Bitcoin mining company reported quarterly losses of 3 cents per share which missed the analyst consensus estimate of earnings of 4 cents per share. Quarterly revenue came in at $42.433 million, missing the analyst consensus estimate of $51.092 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
TeraWulf shares tumbled 9.3% to $2.03 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>StoneCo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) shares declined 9.3% to $15.10 in pre-market trading after the company reported first-quarter financial results.</li>
<li>TMC the metals company Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) shares fell 8.6% to $1.39 in pre-market trading after the company reported first-quarter financial results.</li>
<li>MMTec, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) shares fell 6% to $4.56 in pre-market trading after surging 31% on Monday.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) shares declined 4.7% to $3.43 in pre-market trading after surging 11% on Monday.</li>
<li>Cognyte Software Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNT#NASDAQ">CGNT</a>) shares declined 4% to $7.37 in pre-market trading.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) shares fell 3.5% to $0.8117 in pre-market trading. Ginkgo Bioworks received a notice of continued listing standard notice from the NYSE.</li>
<li>Maplebear Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) shares declined 3.4% to $33.56 in pre-market trading. Maplebear, last week, posted first-quarter financial results.</li>
<li>Burford Capital Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) fell 3% to $14.07 in pre-market trading following a 6% decline on Monday.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38807214/investor-optimism-improves-but-dow-snaps-8-session-winning-streak">Investor Optimism Improves, But Dow Snaps 8-Session Winning Streak</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

Pre-Market Outlook

CART

CGNT

STNE

WULF

TeraWulf Posts Weak Results, Joins StoneCo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Oppenheimer analyst Matthew Biegler maintains Fulcrum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULC#NASDAQ">FULC</a>) with a Outperform and lowers the price target from $16 to $14.

FULC

Oppenheimer Maintains Outperform on Fulcrum Therapeutics, Lowers Price Target to $14

Evercore ISI Group analyst Cory Kasimov initiates coverage on Arcellx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLX#NASDAQ">ACLX</a>) with a Outperform rating and announces Price Target of $85.

ACLX

Evercore ISI Group Initiates Coverage On Arcellx with Outperform Rating, Announces Price Target of $85

Evercore ISI Group analyst Cory Kasimov initiates coverage on BridgeBio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) with a Outperform rating and announces Price Target of $50.

BBIO

Evercore ISI Group Initiates Coverage On BridgeBio Pharma with Outperform Rating, Announces Price Target of $50

As pro-Trumpers called out <a href="https://www.benzinga.com/news/24/03/38013475/donald-trump-manhattan-da-alvin-bragg-clash-over-scope-of-gag-order-amid-ex-presidents-attacks-again">New York District Attorney Alvin Bragg, </a>who brought the criminal case against Donald Trump, alleging that he falsified his business record to conceal damaging information from the American voters before the 2016 election, Tesla CEO Elon Musk weighed in on the proceedings.
What Happened: Commenting on the ongoing hush-money case trial, Arizona Congressional candidate Blake Masters, a Republican and protege of entrepreneur and venture capitalist Peter Thiel, slammed Bragg in a post on X, formerly Twitter, on Monday. &#8220;It&#8217;s hard to put into words the staggering corruption of Alvin Bragg&#8217;s kangaroo court in New York City,&#8221; he said.
The lead prosecutor was a Democratic National Convention consultant and was number 3 at President Joe Biden's Department of Justice before being hired by Bragg, he said. The other lead prosecutor donated over $1,000 to Biden and ActBlue in 2020, he added.
Masters also noted that the Acting New York State Supreme Court Justice Juan Merchan donated to Biden and his daughter The judge is a left-wing activist who is using the trial to raise money for Democrats. &#8220;The lead witness is a convicted perjurer who is selling t-shirts of Trump in jail on TikTok,&#8221; he said.
&#8220;This whole thing is a joke and wouldn&#8217;t be happening if President Trump wasn&#8217;t leading in every swing state poll.&#8221;
Foundation For Freedom Online Executive Director Mike Benz concurred with Masters and said, &#8220;The judge is so financially conflicted he wouldn't even be allowed on the jury.&#8221; Referring to former Trump lawyer Michael Cohen, who testified on Monday, he said, &#8220;The star witness is a multi-crime convicted felon who in most states wouldn't even be allowed to vote.&#8221;
Musk chimed in and said, &#8220;The more unfair the attacks on Trump seem to the public, the higher he will rise in the polls.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The more unfair the attacks on Trump seem to the public, the higher he will rise in the polls
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1790119720504447417?ref_src=twsrc%5Etfw">May 13, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The results of a New York Times/Sienna poll published on Monday showed that <a href="https://www.benzinga.com/general/politics/24/05/38804590/trump-vs-biden-new-swing-state-poll-reveals-winner-one-key-2024-election-issue-could-influence-r">Trump was leading in five of the six key swing states.</a>
See Also: <a href="https://www.benzinga.com/best-penny-stocks">Best Penny Stocks</a>
In a separate post, Benz shared a screenshot of the results of the poll, which showed Trump led either by majority support or by the singularity of votes in all states but Michigan. &#8220;We&#8217;re gonna need more prosecutors,&#8221; he said, taking a swipe at Bragg and the team.
Musk quipped in and said, the betting odds, however, projected a &#8220;much tighter race.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The betting odds on a Trump victory currently show a much tighter race
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1790116956135153813?ref_src=twsrc%5Etfw">May 13, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Musk also reacted to a post by conservative media Babylon Bee, which said, &#8220;Latest Polls Show Biden Will Need Twice As Many Fake Ballots To Win Election This Year.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f602;
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1790242234777968753?ref_src=twsrc%5Etfw">May 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It&#8217;s Important: Most nationwide opinion polls project a very close race between presumptive candidates from either side of the aisle. That said, voters are generally disgruntled with both candidates, potentially for different reasons.
A recent FT/Michigan Ross poll found that Biden has anemic approval ratings both for his handling of the economy and his handling of his job as president. Inflation was mentioned as a primary economic concern by most voters. Trump, on the other hand, is stymied by the four criminal cases pending against him. The consolation is that only the hush-money case could reach a verdict before the Nov. 5 election.
Musk has largely sided with the Republicans this election cycle. He and Biden share a fractious relationship, primarily due to the latter ignoring Tesla in his discussions about climate change and electric vehicles. Trump was rumored to have met with Musk in early March, reportedly to seek campaign funding. 
Read Next: <a href="https://www.benzinga.com/news/24/05/38791491/biden-vs-trump-incumbent-fails-to-win-voter-confidence-to-steer-economy-as-new-poll-identifies-infla">Biden Vs. Trump: Incumbent Fails To Win Voter Confidence To Steer Economy As New Poll Identifies Inflation As Major Pushback</a>
Photos courtesy: Shutterstock

Media

Elon Musk Says The More Unfair Attacks On Trump Seem 'The Higher He Will Rise In Polls' After GOP House Contender Slams Alvin Bragg's 'Kangaroo Court'

Evercore ISI Group analyst Cory Kasimov initiates coverage on Neurocrine Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) with a Outperform rating and announces Price Target of $175.

NBIX

Evercore ISI Group Initiates Coverage On Neurocrine Biosciences with Outperform Rating, Announces Price Target of $175

Fulgent Genetics (FLGT) Q4 2023 Earnings Call Transcript

Piper Sandler analyst David Westenberg maintained a Hold rating on Fulgent Genetics (FLGT – Research Report) today and set a price target of $25.00...

Piper Sandler Sticks to Its Hold Rating for Fulgent Genetics (FLGT)

Notable earnings before Friday's open

Fulgent Genetics Q1 2024 Earnings Preview

Fulgent Genetics reports mixed Q1 results; reaffirms FY24 outlook

The latest announcement is out from Fulgent Genetics Inc (FLGT). The Company has recently updated its investor presentation on May 3, 2024, and it ...

Fulgent Genetics Releases Updated Investor Presentation

Today, several major companies are expected to report earnings: Cheniere Energy (LNG), XPO (XPO), The Hershey Company (HSY), Magna International (M...

Options Volatility and Implied Earnings Moves Today, May 03, 2024

Fulgent Genetics, Inc. (FLGT) Q1 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Fulgent Genetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/flgt-stock-quote/">FLGT</a>) just reported results for the first quarter of 2024.<ul><li>Fulgent Genetics reported earnings per share of -1 cent. This was above the analyst estimate for EPS of -32 cents.</li><li>The company reported revenue of $64.49 million.</li><li>This was 1.34% worse than the analyst estimate for revenue of $65.36 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/flgt-stock-earnings-fulgent-genetics-for-q1-of-2024/">FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fulgent Genetics (FLGT – Research Report), Cigna (...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Fulgent Genetics (FLGT), Cigna (CI) and PROCEPT BioRobotics (PRCT)

ADNT

AMRX

ASIX

BCPC

CBOE

CBRE

CMLS

CRBG

ESNT

FUBO

FYBR

GPRE

GTLS

ISNPY

JOUT

MITT

NMRK

PAGP

PRCT

PRLB

SCGLF

SMLP

TRMB

UNIT

Press Releases

Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023

Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting

Fulgent Reports Third Quarter 2023 Financial Results

Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting

Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference

Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing

Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024

Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results

Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fulgent Genetics Stock (NASDAQ:FLGT), Short Interest Report

People Also Watch